MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY [PDF]
Педиатрическая фармакология, 2012 Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations.
I. V. Davydova +3 more
doaj +2 more sources
A comparative study of the impact of prescription and non-prescription mucolytic agents on respiratory disease management in a community-based population [PDF]
Frontiers in PharmacologyIntroductionRespiratory disease significantly impacts quality of life at the same time economic burden. Mucolytic agents are widely used in respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and upper respiratory tract ...
Jayshree Shriram Dawane +2 more
doaj +2 more sources
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies [PDF]
European Journal of Clinical Investigation, Volume 56, Issue 10, October 2026.COPD is a heterogeneous disease driven by overlapping neutrophilic and eosinophilic inflammatory pathways. This review highlights the shift from symptom‐based treatment toward phenotype‐ and biomarker‐directed care. Blood eosinophils, FeNO, and IgE predict corticosteroid responsiveness and identify candidates for biologic therapy.
Sasha Raman +3 more
wiley +2 more sources
World Journal of Otorhinolaryngology-Head and Neck Surgery, 2018 Objective: The aim of this study was to evaluate clinical practice patterns of preoperative and postoperative medical therapies immediately surrounding sinus surgery for chronic rhinosinusitis (CRS) by Chinese otolaryngologists.
Zhen-Xiao Huang +4 more
doaj +2 more sources
ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY [PDF]
Педиатрическая фармакология, 2014 The primary objective in the mucoviscidosis therapy is to ensure normal rheology of respiratory secretion for effective evacuationthereof from the bronchial tree and nasal sinuses.
O. I. Simonova, Yu. V. Gorinova
doaj +2 more sources
Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024) [PDF]
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.ABSTRACT Purpose The World Health Organization (WHO) began recognizing drug shortages as a global issue in 2014, impacting health systems and patient care. Shortages arise from supply chain disruptions, production issues, and mismatches between supply and demand, aggravated by insufficient mechanisms for forecasting and communication. Methods The study
Raphaella Oliveira Martins de Lima +6 more
wiley +2 more sources
Mucolytics for Intubated Asthmatic Children: A National Survey of United Kingdom Paediatric Intensive Care Consultants [PDF]
Critical Care Research and Practice, 2015 Aim. The extent to which mucolytics are utilised in mechanically ventilated asthmatic children is unknown. We sought to establish current practice in the United Kingdom (UK) including choice of mucolytic, dose, and frequency of utilisation. Methods.
Aarjan Peter Snoek, Joe Brierley
doaj +2 more sources
Вопросы современной педиатрии, 2014 The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including ...
Ye. L. Amelina +27 more
doaj +2 more sources
An Epidemiological Study on the Effectiveness of Nasturtium Herb and Horseradish Root (Angocin® Anti-Infekt N) as well as Other Phytopharmaceuticals, Synthetic Products, and Antibiotics on the Course of Acute Upper Respiratory Tract Infection (aURTI) [PDF]
AntibioticsBackground: The goal of this study was to evaluate whether medical recommendation of Angocin® Anti-Infekt N (hereafter referred to as Angocin®) on the day of diagnosis of an acute upper respiratory tract infection (aURTI) or acute sinusitis (AS) is ...
Nina Kassner +3 more
doaj +2 more sources
Mucolytic Therapy in COPD: Patient Usage and Preferences in Real-World Italian Settings [PDF]
International Journal of COPDSalvatore D’Antonio,1 Alfio Pennisi,2 Mario Cazzola3 1Italian COPD Patients Association, Rome, Italy; 2Department of Respiratory Medicine, Hospital Clinic ‘Casa di Cura Riabilitativa Calaciura’, Catania, Italy; 3Unit of Respiratory Medicine, Department ...
D'Antonio S, Pennisi A, Cazzola M
doaj +2 more sources